Bringing the fundamentals into focus…
Back to Eupraxia Pharmaceuticals Inc.
How Eupraxia Pharmaceuticals Inc. stacks up
EPRX · against 429 other Healthcare companies of similar size
Overall
36/ 100
Below the middle of the pack.
Ranked #301 of 430 · scores higher than 29% of peers
Bars: peers in each 10-point band of the overall score74 peers with an overall score of 30–39, including EPRX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around EPRX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 4 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 294 | 42.8B INR (≈$513M) | 37 | 30 | 23 | 39 | 1 / 2 | |
| 294 | 394M USD | 37 | 8 | 52 | 22 | 1 / 2 | |
| 301 | 3.0B CNY (≈$427M) | 36 | 49 | 21 | 43 | 2 / 2 | |
| 301 | 334M USD | 36 | 8 | — | 10 | 0 / 2 | |
| 301 | 455M USD | 36 | 8 | — | 9 | 0 / 2 | |
| 301 | 533M USD | 36 | 8 | 32 | 25 | 0 / 2 | |
| 301 | 879M USD | 36 | 8 | 56 | 6 | 0 / 2 | |
| 301 | 255M USD | 36 | 8 | 64 | 10 | 1 / 2 | |
| 301 | 388M USD | 36 | 8 | — | 12 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score